title: [Treatment of thrombotic thrombocytopenic purpura with rituximab. Report of eight cases].
abstract: Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with appropriate treatment. In patients refractory to standard treatment with plasmapheresis there is no certainty about the best therapeutic strategy. This report shows our experience in eight refractory patients who survived after treatment with rituximab.
authors.forename: Mauricio
authors.initials: M
authors.lastname: Sarmiento Maldonado
authors.forename: Pablo
authors.initials: P
authors.lastname: Bertín Cortés-Monroy
authors.forename: Pablo
authors.initials: P
authors.lastname: Lira Vergara
authors.forename: María Alejandra
authors.initials: MA
authors.lastname: Rodríguez Ingles
authors.forename: María José
authors.initials: MJ
authors.lastname: García Rodríguez
authors.forename: Pablo
authors.initials: P
authors.lastname: Ramírez Villanueva
authors.forename: Mauricio
authors.initials: M
authors.lastname: Ocqueteau Tachini
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy*; D012008:Recurrence; D012189:Retrospective Studies; D000069283:Rituximab / Q000493:pharmacokinetics / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000069283:Rituximab